A close cousin of the bacterium that debilitated thousands of World War I soldiers has been isolated at UCSF from a patient who had been on an international vacation. The woman, who has since recovered, suffered from symptoms similar to malaria or typhoid fever, two infections that can occur in returning travelers.
As stem cells in the blood grow older, genetic mutations accumulate that could be at the root of blood diseases that strike people as they age, according to work done in mice by researchers at the Stanford University School of Medicine.
Chemotherapy temporarily hinders the body’s immune response, creating a concern that it may interfere with the promising new cancer vaccines being used against brain tumors.
Australian Health Minister Tony Abbott and Immigration Minister Kevin Andrews have advised Prime Minister John Howard to adopt a policy that would require HIV-positive migrants to report to health authorities within one month of arriving in Australia or risk losing their visas.
University of Florida researchers have begun a clinical study of oral insulin to prevent or delay type 1 diabetes in people at risk for the disease.
Scientists at the Southwest Foundation for Biomedical Research have developed a new tool in the battle against a potential biological weapon, Lassa fever, which kills several thousand people each year and leaves thousands more with disabilities such as deafness and liver damage.
A new study conducted by researchers from the University of Verona and the Institute G. Gaslini in Genova, Italy, confirms the pivotal role played by Cytomegalovirus infection in the pathogenesis of atherosclerosis.
Iomai Corporation (Nasdaq: IOMI) announced interim results from a Phase 1 clinical trial of its patch-based vaccine for seasonal influenza.
AIDS Healthcare Foundation (AHF), the largest AIDS healthcare, prevention and education provider in the United States and operator of free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia unveiled a public awareness campaign targeting negative direct-to-consumer advertising of HIV/AIDS drugs by pharmaceutical companies.
A study from scientists at the University of Freiburg, Germany, and their collaborators at the National Cancer Institute (NCI), part of the National Institutes of Health, has pinpointed a potential mechanism for resistance of Ewing?s sarcoma, a type of bone cancer, to a protein that may be useful in fighting cancer ? and a possible method for overcoming this resistance.